Giulio Francia to Aged
This is a "connection" page, showing publications Giulio Francia has written about Aged.
Connection Strength
0.085
-
Manca ML, Michelangeli A, Bocci G, Orlandi P, Allegrini G, Kirken RA, Francia G, Georgiev V. Mathematical analysis of metronomic chemotherapy response in metastatic gastrointestinal cancer: identifying critical parameters from clinical data. Sci Rep. 2026 Jan 11; 16(1):1571.
Score: 0.024
-
Qiu C, Wang X, Francia G, Casiano CA, Zhang JY. A panel of four autoantibodies to tumour-associated antigens in patients with prostate cancer and its potential for multi-cancer detection. Br J Cancer. 2026 Feb; 134(3):493-503.
Score: 0.024
-
Di Desidero T, Antonelli A, Orlandi P, Ferrari SM, Fioravanti A, Al? G, Fontanini G, Basolo F, Francia G, Bocci G. Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer. Cancer Lett. 2017 12 28; 411:35-43.
Score: 0.014
-
Di Desidero T, Derosa L, Galli L, Orlandi P, Fontana A, Fioravanti A, Marconcini R, Giorgi M, Campi B, Saba A, Lucchesi S, Felipetto R, Danesi R, Francia G, Allegrini G, Falcone A, Bocci G. Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients. Invest New Drugs. 2016 12; 34(6):760-770.
Score: 0.013
-
Derosa L, Galli L, Orlandi P, Fioravanti A, Di Desidero T, Fontana A, Antonuzzo A, Biasco E, Farnesi A, Marconcini R, Francia G, Danesi R, Falcone A, Bocci G. Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients. Cancer. 2014 Dec 15; 120(24):3923-31.
Score: 0.011